In swansong, FDA chief defends drug approval process

WASHINGTON (Reuters) - In her final speech after six years as commissioner of the U.S. Food and Drug Administration, Dr. Margaret Hamburg defended the agency's drug approval standards against critics seeking weaker regulatory standards.

via Reuters: Health News Read More Here..